We are live on ! Find out more
CTIC

CTI BioPharma Corp. (DE) Common Stock

Delisted

CTIC was delisted on the 23rd of June, 2023.

90 hedge funds and large institutions have $148M invested in CTI BioPharma Corp. (DE) Common Stock in 2014 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 32 increasing their positions, 13 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

548% more call options, than puts

Call options by funds: $2.61M | Put options by funds: $402K

146% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 13

47% more capital invested

Capital invested by funds: $100M → $148M (+$47M)

38% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 16

6% more funds holding

Funds holding: 8590 (+5)

Holders
90
Holders Change
+5
Holders Change %
+5.88%
% of All Funds
2.4%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
22
Increased
32
Reduced
13
Closed
16
Calls
$2.61M
Puts
$402K
Net Calls
+$2.2M
Net Calls Change
+$441K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
76
BlackRock
New York
$10K +$1.46K +63 +18%
Teacher Retirement System of Texas
77
Teacher Retirement System of Texas
Texas
$9K -$1.92K -83 -18%
LTFS
78
Ladenburg Thalmann Financial Services
Florida
$3K
VIA
79
Vantage Investment Advisors
Pennsylvania
$2K
Group One Trading
80
Group One Trading
Illinois
$2K +$2.36K +102 New
PNC Financial Services Group
81
PNC Financial Services Group
Pennsylvania
$1K -$19K -820 -94%
WTB
82
Washington Trust Bank
Washington
$1K
ED
83
Exane Derivatives
France
$700 +$694 +30 New
SM
84
Sabby Management
Florida
$578 +$566K +24,500 New
Manulife (Manufacturers Life Insurance)
85
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$229 +$22.2K +962 +11%
HCM
86
Highbridge Capital Management
New York
-$311K -12,841 Closed
EEG
87
E.E. Geduld
-$97K -4,000 Closed
NCCM
88
Nine Chapters Capital Management
New Jersey
-$77K -3,190 Closed
FNYS
89
First New York Securities
New York
-$74K -3,056 Closed
AL
90
Airain Ltd
Guernsey
-$68K -2,812 Closed
Ameriprise
91
Ameriprise
Minnesota
-$62K -2,550 Closed
TRCT
92
Tower Research Capital (TRC)
New York
-$51.5K -2,227 Closed
JP Morgan Chase
93
JP Morgan Chase
New York
-$44K -1,791 Closed
M&T Bank
94
M&T Bank
New York
-$34K -1,407 Closed
HSBC Holdings
95
HSBC Holdings
United Kingdom
-$31K -1,283 Closed
AIP
96
Ameritas Investment Partners
Nebraska
-$31K -1,281 Closed
BNP Paribas Financial Markets
97
BNP Paribas Financial Markets
France
-$19.9K -822 Closed
FWM
98
Focused Wealth Management
New York
-$2K -80 Closed
Fifth Third Bancorp
99
Fifth Third Bancorp
Ohio
-$1K -48 Closed
MPWT
100
MassMutual Private Wealth & Trust
Connecticut
-$484 -20 Closed

CTIC Hedge Fund Activity: Q4 2014 in Review

90 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in CTI BioPharma Corp. (DE) Common Stock (CTIC) for Q4 2014, worth a combined $148M — up 47% from $100M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new CTIC positions and 16 closed out — a net gain of 6 holders — while 32 added to existing stakes and 13 trimmed.

The largest buyer was Eagle Asset Management, adding an estimated $11.2M. The largest seller was Renaissance Technologies, cutting an estimated $978K.

  • 90 institutional investors held CTI BioPharma Corp. (DE) Common Stock (CTIC) as of Q4 2014, up from 85 in Q3 2014.
  • Funds reported $148M of CTI BioPharma Corp. (DE) Common Stock stock for Q4 2014, up 47% quarter-over-quarter.
  • 22 funds opened new CTI BioPharma Corp. (DE) Common Stock positions in Q4 2014 and 16 closed out, a net change of +6 holders.
  • The largest CTI BioPharma Corp. (DE) Common Stock buyer in Q4 2014 was Eagle Asset Management, an estimated $11.2M added.
  • The largest CTI BioPharma Corp. (DE) Common Stock seller in Q4 2014 was Renaissance Technologies, an estimated $978K sold.

Based on aggregated 13F filings for Q4 2014.